Advertisement
Research ArticleArticle

Cisplatin enhances PERK- and CD95-dependent MDA-7/IL-24-induced killing in ovarian carcinoma cells

Adly Yacoub, Renyan Liu, Margaret A Park, Hossein A Hamed, Rupesh Dash, Danielle N Schramm, Devanand Sarkar, Igor P Dimitriev, Jessica K Bell, Steven Grant, Nicholas P Farrell, David T Curiel, Paul B Fisher and Paul Dent
Molecular Pharmacology November 12, 2009, mol.109.061820; DOI: https://doi.org/10.1124/mol.109.061820

Article Figures & Data

Additional Files

  • Data Supplement

    Files in this Data Supplement:

    • Data Supplement - Figure S1. MDA-7/IL-24 activates PERK, JNK and p38 MAPK and inactivates ERK1/2 in SKOVIII cells...
      Figure S2. GST-MDA-7 enhances BBR3464 lethality in primary human GBM cells...
      Figure S3. GST-MDA-7 enhances cisplatin lethality in primary human GBM cells...
      Figure S4. Ad.5-mda-7 and cisplatin interact to kill primary human ovarian cancer cells in vitro...
      Figure S5. Knock down of ATG5 suppresses Ad.5-mda-7�induced cell killing in OCCs...
      Figure S6. Ad.5-mda-7 and cisplatin + paclitaxel treatment interact in a greater than additive fashion to kill ovarian cancer cells in colony formation assays...
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Cisplatin enhances PERK- and CD95-dependent MDA-7/IL-24-induced killing in ovarian carcinoma cells

Adly Yacoub, Renyan Liu, Margaret A Park, Hossein A Hamed, Rupesh Dash, Danielle N Schramm, Devanand Sarkar, Igor P Dimitriev, Jessica K Bell, Steven Grant, Nicholas P Farrell, David T Curiel, Paul B Fisher and Paul Dent
Molecular Pharmacology November 12, 2009, mol.109.061820; DOI: https://doi.org/10.1124/mol.109.061820
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement